Viewing Study NCT00270556


Ignite Creation Date: 2025-12-24 @ 11:16 PM
Ignite Modification Date: 2026-01-29 @ 2:16 PM
Study NCT ID: NCT00270556
Status: COMPLETED
Last Update Posted: 2008-04-10
First Post: 2005-12-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Comparator Study of Substitution of Tenofovir or Abacavir Receiving Thymidine Analogue as Part of HAART.
Sponsor: Gilead Sciences
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Treatment Experienced View